Specific to nonspecific binding in radiopharmaceutical studies: it's not so simple as it seems!

Nuclear Medicine and Biology

Volumn 36, Issue 3, 2009, Pages 235-237

  Eckelman, William C ^a   Kilbourn, Michael R ^b   Mathis, Chester A ^c  

^a Molecular Tracer LLC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; TRACER;

BINDING AFFINITY; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; IN VITRO STUDY; IN VIVO STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

DRUG DISCOVERY; HUMANS; LIGANDS; RADIOPHARMACEUTICALS;

EID: 62549156233     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.12.002     Document Type: Editorial

References (17)

1. Eckelman W.C., Kilbourn M.R., and Mathis C.A. Discussion of targeting proteins in vivo: in vitro guidelines. Nucl Med Biol 33 4 (2006) 449-451
2. Eckelman WC, editor. Receptor Binding Radiotracers. Boca Raton (Fla): CRC Press, 1982; vols. I;1-180 and II;1-230
3. Eckelman W.C., Reba R.C., Gibson R.E., Rzeszotarski W.J., Vieras F., Mazaitis J.K., et al. Receptor binding radiotracers: a class of potential radiopharmaceuticals. J Nucl Med 20 (1979) 350-357
4. Katzenellenbogen J.A., Heiman D.F., Carlson K.E., and Lloyd J.E. In vitro and in vivo steroid receptor assays in the design of estrogen radiopharmaceuticals. In: Eckelman W.C. (Ed). Receptor binding radiotracers vol. I (1982), CRC Press, Boca Raton (Fla) 93-126
5. 125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies. J Cereb Blood Flow Metab 10 (1990) 781-807
6. 18F]-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab 24 (2004) 309-322
7. Kessler R.M., Whetsell W.O., Ansari M.S., Votaw J.R., Depaulis T., Clanton J.A., et al. Identification of extrastriatal dopamine D2 receptors in postmortem human brain with I-125 epidepride. Brain Res 609 (1993) 237-243
8. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., and Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15 3 (1984) 217-227
9. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cerebral Blood Flow Metab 27 (2007) 1533-1539
10. Christian B.T., Narayanan T.K., Shi B., and Mukherjee J. Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(1)F]fallypride in nonhuman primates. Synapse 38 1 (2000) 71-79
11. Jagoda E.M., Lang L., Tokugawa J., Simmons A., Ma Y., Contoreggi C., et al. Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT. Synapse 59 6 (2006) 330-341
12. Passchier J., and van Waarde A. Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system. Eur J Nucl Med 28 1 (2001) 113-129
13. Zimmer L., Mauger G., Le Bars D., Bonmarchand G., Luxen A., and Pujol J.F. Effect of endogenous serotonin on the binding of the 5-HT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic b measurements combined with microdialysis. J Neurochem 80 (2002) 278-286
14. Budinger T.J. Introduction. In: Eckelman W.C. (Ed). Receptor binding radiotracers vol. II (1982), CRC Press, Boca Raton (Fla) 87-94
15. Atkins F.B., and Goodenough D.J. Simulated uptake ratio requirements for spherical lesions imaged with a conventional scintillation camera. In: Eckelman W.C. (Ed). Receptor binding radiotracers vol. II (1982), CRC Press, Boca Raton FL 95-107
16. Hoffman E.J. Instrumentation for quantitative tomographic determination off concentration of positron-emitting receptor binding. In: Eckelman W.C. (Ed). Receptor binding radiotracers vol. II (1982), CRC Press, Boca Raton, FL 141-173
17. Raylman R.R., Kison P.V., and Wahl R.L. Capabilities of two- and three-dimensional FDGPET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med 26 1 (1999) 39-45